Abstract
Publisher Summary This chapter describes the procedures and approaches used to investigate the role of ceramide and other sphingolipids in the suppression of CYP2C11 expression by interleukin-1 in primary rat hepatocytes. The majority of P450 gene products are down-regulated by immunomodulators, but members of the CYP4A family are induced under some circumstances. Hydrolysis of sphingomyelin (SM) to ceramide plus phosphorylcholine, catalyzed by sphingomyelinase (SMase), is an early event in cellular signaling pathways for the cytokines interleukin-1 and tumor necrosis factor-α in various cell types. A cytokine or other hormone regulates P450 expression through the SM/ceramide pathway and that hormone can elicit the hydrolysis of cellular SM, with a concomitant generation of ceramide. The cytokine-induced turnover of SM in hepatocytes is not accompanied by stoichiometric formation of ceramide under all experimental conditions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.